Pharmaceutical companies have become cautious with regard to mergers and acquisitions (M&As) as the business environment remains challenging due to pricing pressure and regulatory interventions in key markets—the US...
Cadila Healthcare, Torrent Pharma eyeing potential merger
The domestic pharmaceuticals sector may be set for a shake-up as Ahmedabad headquartered Cadila HealthcareBSE -0.22 % led by Pankaj Patel and the Mehta family backed Torrent Pharmaceuticals are re-evaluating a potential...
Aurobindo Pharma, Intas in race for Teva’s European assets
Aurobindo Pharma Ltd and Intas Pharmaceuticals Ltd are in the race to acquire part of the European assets of Israeli generic drugmaker Teva Pharmaceutical Industries Ltd in a deal that, if completed, could be the...
Aurobindo Pharma may buy Portugal’s Generis, deal likely to be valued at $200 million
MUMBAI: Hyderabad-based Aurobindo PharmaBSE -0.63 % has expressed preliminary interest in acquiring Portuguese drug maker Generis Farmaceutica for about $200 million. Generis has a presence across anti-infective...
Dilip Shanghvi, M&A artist behind India’s best stock, now faces his greatest test
Mumbai: When Dilip Shanghvi wants something, he has a track record of getting it. One executive, Srinivas Lanka, recalls the founder of Sun Pharmaceuticals Industries Ltd calling more than 100 times over three years...
Sun Pharma strikes distribution alliance with Mitsubishi Tanabe in Japan
MUMBAI: Sun PharmaBSE 0.24 % has announced a distribution alliance in Japan with Mitsubishi Tanabe for a phased transfer of manufacturing and marketing rights of 14 products that it acquired fromNovartisBSE 0.49 %...
China rolls out sops for investments to Indian pharma companies
MUMBAI: China, the second largest pharmaceutical market in the world after US, is luring Indian drug companies to set up greenfield operations in that country. To roll out the red carpet, the local government has...
Samara Capital to stay on buyout course
Samara Capital has invested 70 per cent of its $320-million second fund, raised in 2013-14, in six companies. Of this, five are controlled (or co-controlled) transactions and only one is minority investment. This is in...
Small is Beautiful
While big ticket acquisitions like the $12.7-billion Tata Steel-Corus deal may draw major headlines and peer’s envy, it is small ticket deals like Dabur buying Balsara group for $35 million or Emani acquiring Zandu...
Indian pharma cos aim for the biggest global buy
Indian pharma cos aim for the biggest global buy This could well be the biggest Indian acquisition in the global pharma space. Two Indian pharma giants and a private equity (PE) player are eyeing Minnesota-based...
Sun Pharma buys Novartis brands for Rs 1,900 cr
Sun Pharmaceuticals, India’s largest drug maker by sales, has acquired Novartis’ branded drug portfolio in Japan for $293 million (Rs 1,900 crore). With this, Sun will gain a strong foothold in Japan, the...
South Africa’s Adcock in talks to sell part of its India business.
South Africa’s second largest drug maker Adcock Ingram is in advanced talks to sell part of its India business to Oaknet Lifesciences, an entrepreneurial venture set up last year by RS Raghav, a former Lupin...